Rowland Thomas Andrew

SVP, HEAD - ESTABLISHED BRANDSANI PHARMACEUTICALS INC (ANIP) · full profile →Form 4 · filed May 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2026Sell(S)459$79.21$36K38K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001507496-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly: